25
edits
Use and Disclosure of Protected Health Information: Difference between revisions
Use and Disclosure of Protected Health Information (view source)
Revision as of 08:43, June 24, 2013
, June 24, 2013no edit summary
No edit summary |
No edit summary |
||
| Line 31: | Line 31: | ||
== Basis for Policy == | == Basis for Policy == | ||
To establish guidelines for the use and disclousre of protected health information (PHI) in accordance with HIPAA. (45 CFR 164.502)<br /> | To establish guidelines for the use and disclousre of protected health information (PHI) in accordance with HIPAA. ([http://www.gpo.gov/fdsys/pkg/CFR-2010-title45-vol1/pdf/CFR-2010-title45-vol1-sec164-502.pdf 45 CFR 164.502])<br /> | ||
<br /> | <br /> | ||
| Line 101: | Line 101: | ||
The ACE may disclose PHI to another covered entity or a healthcare provider for the payment activities of the entity that receives the information. | The ACE may disclose PHI to another covered entity or a healthcare provider for the payment activities of the entity that receives the information. | ||
UNMC shall enter into a business associate agreement with outside entities performing services on its behalf that required PHI to perform the services. See Contracts Policy. | UNMC shall enter into a business associate agreement with outside entities performing services on its behalf that required PHI to perform the services. See [[Contracts|Contracts Policy]]. | ||
Individuals shall sign an acknowledgement of receipt of the Notice of Privacy Practices when they first access the ACE for direct treatment, explaining how their PHI may be used and disclosed. See Notice of Privacy Practices Policy. | Individuals shall sign an acknowledgement of receipt of the Notice of Privacy Practices when they first access the ACE for direct treatment, explaining how their PHI may be used and disclosed. See Notice of Privacy Practices Policy. | ||